Researcher profile
Alex Dickens
Affiliations
Organizations
Public evidence
6 connected articles
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMCEffects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.2024 · Europe PMCNovel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD).2024 · Europe PMCDynamics of the Lipidome in a Colon Simulator.2023 · Europe PMCObesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB<sub>1</sub> receptor availability.2022 · Europe PMCLinks between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis.2020 · Europe PMC
Registered research
Connected studies
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Studynct04605393Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulationnct05032807Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Rationct05170217
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.